Capula Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,991
Closed -$606K 968
2026
Q1
$606K Buy
6,991
+4,405
+170% +$422K ﹤0.01% 469
2025
Q4
$248K Sell
2,586
-275
-10% -$26.7K ﹤0.01% 532
2025
Q3
$272K Buy
2,861
+1,728
+153% +$159K ﹤0.01% 542
2025
Q2
$98.8K Sell
1,133
-169
-13% -$14.3K ﹤0.01% 505
2025
Q1
$117K Buy
+1,302
New +$117K ﹤0.01% 605
2024
Q4
Sell
-4,312
Closed -$388K 512
2024
Q3
$388K Buy
+4,312
New +$363K ﹤0.01% 274
2023
Q2
Sell
-5,278
Closed -$454K 647
2023
Q1
$426K Sell
5,278
-58,150
-92% -$4.74M 0.01% 491
2022
Q4
$4.93M Sell
63,428
-24,957
-28% -$2.02M 0.07% 260
2022
Q3
$7.14M Buy
+88,385
New +$7.94M 0.1% 210
2021
Q4
Sell
-22,462
Closed -$2.81M 550
2021
Q3
$2.81M Buy
22,462
+1,058
+5% +$137K 0.03% 343
2021
Q2
$2.66M Buy
21,404
+18,970
+779% +$2.38M 0.04% 259
2021
Q1
$288K Buy
+2,434
New +$285K 0.01% 426
2020
Q3
Sell
-24,905
Closed -$2.28M 256
2020
Q2
$2.28M Buy
24,905
+21,430
+617% +$2.05M 0.08% 197
2020
Q1
$313K Buy
+3,475
New +$370K 0.01% 344

Other funds holding MDT

Capula Management's MDT Position: Q2 2026 in Review

Capula Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 6,991 shares — an estimated $606K sold.

Capula Management first reported a position in MDT in Q1 2020 and held it in 14 quarters. The position peaked at $7.14M in Q3 2022. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Capula Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Capula Management sold 6,991 Medtronic shares in Q2 2026, an estimated $606K.
  • Capula Management first reported a position in Medtronic in Q1 2020 and held it in 14 quarters.
  • Capula Management's Medtronic position peaked at $7.14M in Q3 2022.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.